Driehaus Capital Management’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$33.7M Buy
195,108
+43,279
+29% +$7.47M 0.27% 122
2025
Q1
$23.7M Buy
151,829
+63,333
+72% +$9.87M 0.23% 135
2024
Q4
$12.2M Sell
88,496
-25,818
-23% -$3.55M 0.1% 224
2024
Q3
$17.1M Buy
114,314
+32,918
+40% +$4.91M 0.15% 190
2024
Q2
$11.1M Sell
81,396
-18,924
-19% -$2.58M 0.11% 207
2024
Q1
$15.2M Buy
+100,320
New +$15.2M 0.15% 196
2023
Q2
Sell
-180,234
Closed -$19.3M 393
2023
Q1
$19.3M Buy
180,234
+7
+0% +$751 0.27% 120
2022
Q4
$22M Buy
180,227
+56,887
+46% +$6.95M 0.33% 98
2022
Q3
$12.7M Sell
123,340
-14,170
-10% -$1.46M 0.19% 158
2022
Q2
$12.8M Buy
137,510
+8,185
+6% +$761K 0.21% 166
2022
Q1
$15.2M Buy
129,325
+48,079
+59% +$5.64M 0.19% 172
2021
Q4
$10.9M Buy
81,246
+99
+0.1% +$13.3K 0.11% 229
2021
Q3
$12.9M Buy
81,147
+24,914
+44% +$3.97M 0.15% 198
2021
Q2
$7.4M Buy
56,233
+3,844
+7% +$506K 0.1% 252
2021
Q1
$6.75M Sell
52,389
-131,931
-72% -$17M 0.1% 256
2020
Q4
$30.7M Buy
184,320
+19,219
+12% +$3.21M 0.5% 56
2020
Q3
$25.5M Sell
165,101
-21,206
-11% -$3.27M 0.52% 49
2020
Q2
$27.6M Buy
186,307
+21,063
+13% +$3.12M 0.67% 34
2020
Q1
$18.6M Buy
165,244
+9,832
+6% +$1.11M 0.62% 42
2019
Q4
$21.6M Buy
155,412
+12,807
+9% +$1.78M 0.57% 44
2019
Q3
$13.7M Sell
142,605
-726
-0.5% -$69.9K 0.45% 60
2019
Q2
$16.5M Sell
143,331
-27,534
-16% -$3.17M 0.52% 54
2019
Q1
$20.1M Buy
170,865
+145,451
+572% +$17.1M 0.76% 29
2018
Q4
$1.59M Sell
25,414
-24,492
-49% -$1.53M 0.07% 244
2018
Q3
$3.54M Buy
49,906
+10,313
+26% +$731K 0.11% 220
2018
Q2
$2.63M Sell
39,593
-9,428
-19% -$627K 0.09% 241
2018
Q1
$3.21M Buy
+49,021
New +$3.21M 0.11% 209
2017
Q4
Sell
-99,328
Closed -$3.6M 529
2017
Q3
$3.6M Buy
+99,328
New +$3.6M 0.14% 192